1. Flegel WA. The genetics of the Rhesus blood group system. Blood Transfus. 2007;5(2):50-7.
3. Jacqueelyn D, Chaote MD. ABO & Rh blood groups. In Principles of transfusion medicine. 2018.
5. Hwang JY, Suh IB, Shim JY, Cho JS, Lee DH. A case of fetal hydrops associated with maternal -D-/-D- phenotype. Korean J Obstet Gynecol. 2006;49(6):1378-82.
6. Um TH, Cho CR, Whang JH, Whang DH, Yoon MS, Han KS. A Case of D--/D-- Phenotype Associated with Moderate Hemolytic Disease of the Newborn. Korean J Blood Transfus. 2007;18(1):61-5.
7. De Vooght KMK, Demir AY, Folman CC, Schutgens REG, van Solinge WW, Kemperman H. Successful transfusion care for a patient with the Rhesus -D- phenotype and antibodies against Rh17 and two additional alloantibodies. Ann Hematol. 2012;91(6):963-4. [
DOI:10.1007/s00277-011-1344-7] [
PMID] [
PMCID]
8. Brumit MC, Carnahan GE, Stubbs JR, Storry J, Reid ME. Moderate hemolytic disease of the newborn (HDN) due to anti-Rh17 produced by a black female with an e variant phenotype. Immunohematology. 2002;18(2):40-2. [
DOI:10.21307/immunohematology-2019-507] [
PMID]
9. Hirose M, Nakanishi K, Kaku S, Moro H, Hodohara K, Aotani H, et al. Fetal Hemolytic Disease due to Anti-Rh17 Alloimmunization. Fetal Diagn Ther. 2004;19(2):182-6. [
DOI:10.1159/000075147] [
PMID]
10. Biswas A, Bajaj A, Philip J, Kushwaha N. A rare case of immune hydrops in an'Elevated D'pregnancy. Glob J Transfus Med. 2020;5(2):221-4. [
DOI:10.4103/GJTM.GJTM_89_20]
11. Dajak S, Ipavec N, Cuk M, Golubic Cepulic B, Mratinovic-Mikulandra J, Milardovic J, et al. The Outcome of Hemolytic Disease of the Fetus and Newborn Caused by Anti-Rh17 Antibody: Analysis of Three Cases and Review of the Literature. Transfus Med Hemother. 2019;47(3):264-71. [
DOI:10.1159/000503012] [
PMID] [
PMCID]
12. Klein H, Anstee D. The Rh blood group system (and LW). In: Klein H, Anstee D, editors. Mollison's Blood Transfusion in Clinical Medicine. 11 ed. London: Blackwell 2005. p. 163-208. [
DOI:10.1002/9780470986868]
13. Rh DG. RHAG blood group systems. Human blood groups. 185. 3 ed. Oxford (UK): Wiley-Blackwell; 2013.
14. Salamat N, Bhatti FA, Hussain A. Anti-Rh17 [Anti-Hr0]: a rare diagnostic and management problem. J Pak Med Assoc. 2004;54(4):215-8.
15. Abolhassan Choobdar F, Milani H, Behrouzi K, Khalesi N, Haghighi B, Manafi A, et al. Anti-Rh17 Alloimmunization: A Rare Case of Severe Hemolytic Disease of the Newborn and Review of the Literature. J Pediatr Rev. 2020;8(1):29-34. [
DOI:10.32598/jpr.8.1.29]
16. Deitenbeck R, Tutschek B, Crombach G, Stannigel H. Successful management of pregnancy and hemolytic disease of the newborn due to anti-HrO in a woman of the D--phenotype. Transfusion. 1999;39(10):1151-2. [
DOI:10.1046/j.1537-2995.1999.t01-1-39101150.x] [
PMID]
17. Diao Y, Song N, Guan Z, Zhang L, Wang Y, Wan M. A case of hemolytic disease of the newborn caused by anti-Hro and anti-e. Proc Chin Acad Med Sci Peking :union: Med Coll. 1990;5(1):58-60.
18. Mimura K, Endo M, Takahashi A, Doi Y, Sakuragi M, Kiyokawa T, et al. Successful management of fetal hemolytic disease due to strong anti-Rh17 with plasma exchange and intrauterine transfusion in a woman with the D-- phenotype. Int J Hematol. 2020;111(1):149-54. [
DOI:10.1007/s12185-019-02735-6] [
PMID]